Cancer Generic Drugs

• 

  Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer

  Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.

• India says its drugs safe despite Ranbaxy generics fraud

  India, known as the "pharmacy to the world", today defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.

• India defends rejection of Novartis patent bid

  An Indian court was fully justified to reject a patent bid by Swiss drug giant Novartis last week, India's trade and industry minister insisted in Geneva on Monday, defending the country's generic drug business.

• Supreme Court backs generics in Novartis drug patent ruling

  India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect access to cheap generic drugs and save lives in developing nations.

• Supreme Court's verdict on Novartis' plea for patent of cancer drug expected today

  The Supreme Court will pronounce today its verdict on Swiss pharma giant Novartis AG's plea for getting its blood cancer drug Glivec patented in India and restraining Indian companies from manufacturing generic drugs.

• Patent board rules against Bayer in cancer drug case

  A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.